Table 2
Open in new tab

Primary outcome analysis

TCS (n = 173)NB‐UVB (n = 169)Combination (n = 175)
Patient response to VNS at 3 months
More noticeable16 (12)26 (19)15 (10)
As noticeable70 (52)57 (42)62 (43)
Slightly less noticeable34 (25)34 (25)47 (33)
A lot less noticeable13 (10)19 (14)17 (12)
No longer noticeable2 (1)02 (1)
Patient response to VNS at 6 months
More noticeable11 (10)23 (20)10 (8)
As noticeable51 (44)37 (33)36 (29)
Slightly less noticeable37 (32)33 (29)45 (36)
A lot less noticeable14 (12)18 (16)28 (22)
No longer noticeable2 (2)2 (2)7 (6)
Participants with primary outcome data at 9 months119 (69)123 (73)128 (73)
Patient response to VNS at 9 months
More noticeable18 (15)27 (22)17 (13)
As noticeable53 (45)33 (27)32 (25)
Slightly less noticeable28 (24)36 (29)45 (35)
A lot less noticeable15 (13)25 (20)27 (21)
No longer noticeable5 (4)2 (2)7 (5)
Patient‐reported treatment successa using VNS at 9 months20 (17)27 (22)34 (27)
TCS (n = 173)NB‐UVB (n = 169)Combination (n = 175)
Patient response to VNS at 3 months
More noticeable16 (12)26 (19)15 (10)
As noticeable70 (52)57 (42)62 (43)
Slightly less noticeable34 (25)34 (25)47 (33)
A lot less noticeable13 (10)19 (14)17 (12)
No longer noticeable2 (1)02 (1)
Patient response to VNS at 6 months
More noticeable11 (10)23 (20)10 (8)
As noticeable51 (44)37 (33)36 (29)
Slightly less noticeable37 (32)33 (29)45 (36)
A lot less noticeable14 (12)18 (16)28 (22)
No longer noticeable2 (2)2 (2)7 (6)
Participants with primary outcome data at 9 months119 (69)123 (73)128 (73)
Patient response to VNS at 9 months
More noticeable18 (15)27 (22)17 (13)
As noticeable53 (45)33 (27)32 (25)
Slightly less noticeable28 (24)36 (29)45 (35)
A lot less noticeable15 (13)25 (20)27 (21)
No longer noticeable5 (4)2 (2)7 (5)
Patient‐reported treatment successa using VNS at 9 months20 (17)27 (22)34 (27)
All data are presented as n (%). NB‐UVB, narrowband ultraviolet B; TCS, topical corticosteroid; VNS, Vitiligo Noticeability Scale. aTreatment success was defined as an answer of either ‘a lot less noticeable’ or ‘no longer noticeable’.
Table 2
Open in new tab

Primary outcome analysis

TCS (n = 173)NB‐UVB (n = 169)Combination (n = 175)
Patient response to VNS at 3 months
More noticeable16 (12)26 (19)15 (10)
As noticeable70 (52)57 (42)62 (43)
Slightly less noticeable34 (25)34 (25)47 (33)
A lot less noticeable13 (10)19 (14)17 (12)
No longer noticeable2 (1)02 (1)
Patient response to VNS at 6 months
More noticeable11 (10)23 (20)10 (8)
As noticeable51 (44)37 (33)36 (29)
Slightly less noticeable37 (32)33 (29)45 (36)
A lot less noticeable14 (12)18 (16)28 (22)
No longer noticeable2 (2)2 (2)7 (6)
Participants with primary outcome data at 9 months119 (69)123 (73)128 (73)
Patient response to VNS at 9 months
More noticeable18 (15)27 (22)17 (13)
As noticeable53 (45)33 (27)32 (25)
Slightly less noticeable28 (24)36 (29)45 (35)
A lot less noticeable15 (13)25 (20)27 (21)
No longer noticeable5 (4)2 (2)7 (5)
Patient‐reported treatment successa using VNS at 9 months20 (17)27 (22)34 (27)
TCS (n = 173)NB‐UVB (n = 169)Combination (n = 175)
Patient response to VNS at 3 months
More noticeable16 (12)26 (19)15 (10)
As noticeable70 (52)57 (42)62 (43)
Slightly less noticeable34 (25)34 (25)47 (33)
A lot less noticeable13 (10)19 (14)17 (12)
No longer noticeable2 (1)02 (1)
Patient response to VNS at 6 months
More noticeable11 (10)23 (20)10 (8)
As noticeable51 (44)37 (33)36 (29)
Slightly less noticeable37 (32)33 (29)45 (36)
A lot less noticeable14 (12)18 (16)28 (22)
No longer noticeable2 (2)2 (2)7 (6)
Participants with primary outcome data at 9 months119 (69)123 (73)128 (73)
Patient response to VNS at 9 months
More noticeable18 (15)27 (22)17 (13)
As noticeable53 (45)33 (27)32 (25)
Slightly less noticeable28 (24)36 (29)45 (35)
A lot less noticeable15 (13)25 (20)27 (21)
No longer noticeable5 (4)2 (2)7 (5)
Patient‐reported treatment successa using VNS at 9 months20 (17)27 (22)34 (27)
All data are presented as n (%). NB‐UVB, narrowband ultraviolet B; TCS, topical corticosteroid; VNS, Vitiligo Noticeability Scale. aTreatment success was defined as an answer of either ‘a lot less noticeable’ or ‘no longer noticeable’.
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close